Welcome to our dedicated page for Balchem news (Ticker: BCPC), a resource for investors and traders seeking the latest updates and insights on Balchem stock.
Balchem Corporation (NASDAQ: BCPC) is a global specialty ingredient manufacturer for health and nutrition markets, and its news flow reflects this focus. Company press releases highlight the development, manufacture and marketing of specialty ingredients that improve and enhance the health and well-being of life on the planet, as well as financial and corporate updates relevant to investors and industry observers.
Visitors to this BCPC news page can review Balchem’s announcements on quarterly financial results, dividend declarations and participation in investor conferences. Recent releases have reported segment-level performance for its Human Nutrition & Health, Animal Nutrition & Health and Specialty Products segments, along with measures such as net sales, earnings from operations, adjusted EBITDA and free cash flow, as described in accompanying Form 8-K filings.
Balchem also issues news related to regulatory and trade developments that affect its markets. For example, the company joined another EU producer in welcoming European Union anti-dumping duties on choline chloride imports from China, emphasizing the importance of fair trade for the EU food and feed supply chain and for maintaining a healthy domestic choline chloride industry.
In addition, Balchem regularly announces its participation in conferences hosted by firms such as CJS Securities, Baird, H.C. Wainwright, Wells Fargo and others, where its leadership presents to the investment community. These updates provide insight into how the company communicates its strategy and segment performance to shareholders and analysts. Investors and researchers can use this news stream to follow Balchem’s financial reporting, capital allocation decisions such as dividends, and its commentary on market and regulatory conditions affecting its human nutrition, animal nutrition and specialty products businesses.
Balchem Corporation (NASDAQ: BCPC) will be represented by CEO Ted Harris and CFO Martin Bengtsson at the CJS Securities 22nd Annual New Ideas for the New Year Conference on January 12, 2022. The company focuses on developing specialty ingredients that enhance health and well-being globally. Balchem operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, providing solutions for food, supplements, pharmaceuticals, and agricultural markets.
On January 10, 2022, Balchem Corporation (NASDAQ: BCPC) will be represented by CEO Ted Harris and CFO Martin Bengtsson at the H.C. Wainwright BIOCONNECT Virtual Conference. Balchem specializes in developing and marketing innovative ingredients aimed at enhancing health across various sectors. Their operations are categorized into three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, providing solutions for the food, supplement, pharmaceutical, and agricultural industries.
Balchem Corporation (NASDAQ: BCPC) has declared a dividend of $0.64 per share, marking a 10.3% increase from the previous year. This dividend will be payable on January 21, 2022, to stockholders of record by December 28, 2021. CEO Ted Harris highlighted this as the thirteenth consecutive increase in dividends, showcasing the company's strong financial performance and the Board’s confidence in its long-term strategies. Balchem is known for its specialty ingredients that enhance health across various industries.
Balchem Corporation (NASDAQ: BCPC) will participate in the Virtual Stephens Annual Investment Conference on November 29, 2021. The company's leadership, including CEO Ted Harris and CFO Martin Bengtsson, will represent Balchem at this significant investment event. Balchem specializes in developing and marketing specialty ingredients, categorized into three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. Their offerings enhance health across various industries, including food, supplements, and pharmaceuticals.
Balchem Corporation (NASDAQ: BCPC) will be represented by its Chairman and CEO, Ted Harris, and CFO, Martin Bengtsson, at the Baird 2021 Global Industrial Conference on November 10, 2021. The presentation will be accessible on Balchem's investor relations website after the event. Balchem specializes in developing and marketing ingredients that enhance health and well-being across various industries, with three main segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Balchem Corporation (NASDAQ: BCPC) reported record third quarter net earnings of $25 million for 2021, up from $21.6 million in Q3 2020. Adjusted net earnings reached $30 million, a rise of 11.3%, and net sales were $197.9 million, reflecting a 13% increase. Each business segment reported record sales, driven by strong performance in Human Nutrition & Health and Animal Nutrition & Health. Adjusted EBITDA improved to $48.3 million, an 8.8% increase. Cash flows from operations were $39.6 million, with free cash flow at $31.1 million, demonstrating robust financial health amidst economic challenges.
Balchem Corporation (NASDAQ: BCPC) will hold a conference call on October 29, 2021, at 11:00 AM ET to discuss its third quarter results. The results will be released before the market opens on the same day. Participants can access the call by dialing 1-877-407-8289 (local 1-201-689-8341) five minutes prior to the start. A replay of the call will be available until November 12, 2021. Balchem specializes in nutritional ingredients across multiple sectors including animal and human health.
Balchem Corporation (NASDAQ: BCPC) reported record second quarter net earnings of $22.7 million for 2021, a 7.6% increase from $21.1 million in Q2 2020. Adjusted net earnings rose to $30.4 million, up 10.3%. Net sales reached $202.4 million, a 16.7% increase driven by growth in all segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. Despite experiencing a $3.8 million loss from a flash flood event, cash flows remained strong with $35.8 million from operations. The effective tax rate increased to 24.3% from 18.7% in the prior year.
Balchem Corporation (NASDAQ: BCPC) is set to present at the Jefferies Virtual Industrials Conference on August 4, 2021, starting at 9:00 a.m. ET. The presentation will be led by Chairman and CEO Ted Harris, along with CFO Martin Bengtsson. Investors and interested parties can listen to the presentation via the provided link.
Balchem specializes in developing, manufacturing, and marketing ingredients aimed at improving health across various industries, including Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Balchem Corporation (NASDAQ: BCPC) will hold a conference call on July 30, 2021, at 11:00 AM ET to discuss its second quarter results. The results will be published before the market opens on the same day. The conference call, hosted by Ted Harris (CEO) and Martin Bengtsson (CFO), will be available for replay until August 13, 2021. Interested parties can access the call by dialing toll-free 1-877-407-8289. More details including financial exhibits will be available on balchem.com.